Rasmus JUST
10Patents
6h-index
21Co-inventors
58Inventor score
Filing activity: May 3, 2013 → Oct 4, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9180169B2 | Glucagon analogues | Human Necessities | 26 | Active |
| US9453064B2 | Glucagon-like-peptide-2 (GLP-2) analogues | Human Necessities | 16 | Active |
| US10100097B2 | GIP-GLP-1 dual agonist compounds and methods | Chemistry; Metallurgy | 12 | Active |
| US9969787B2 | Glucagon-like-peptide-2 (GLP-2) analogues | Human Necessities | 12 | Active |
| US9975939B2 | Glucagon analogues | Human Necessities | 11 | Active |
| US10131702B2 | Glucagon-GLP-1-GIP triple agonist compounds | Human Necessities | 6 | Active |
| US10253080B2 | Glucagon-like-peptide-2 (GLP-2) analogues | Human Necessities | 1 | Active |
| US10766939B2 | Amylin analogues | Human Necessities | 1 | Active |
| US10253081B2 | Glucagon analogues | Human Necessities | 0 | Active |
| US11111285B2 | Glucagon-GLP-1-GIP triple agonist compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.